TRANSPLANT PROCEDURE PHASE. From day myeoloblative or immunoablative therapy begins through discharge. • Inpatient or outpatient, including professional, room and board, nursing, pharmacy and all other ancillary services for recipient. • Marrow ablative or immunoablative therapy (total body irradiation and/or chemotherapy) • Marrow or cord acquisition • Transplant
Appears in 4 contracts
Samples: Ipa Services Agreement (Prospect Medical Holdings Inc), Quality Incentive Program (Prospect Medical Holdings Inc), Ipa Services Agreement (Prospect Medical Holdings Inc)
TRANSPLANT PROCEDURE PHASE. From day myeoloblative or immunoablative therapy begins through discharge. • Inpatient or outpatientourpatient, including professional, room and board, nursing, pharmacy and all other ancillary services for recipient. • Marrow ablative or immunoablative therapy (total body irradiation and/or chemotherapy) • Marrow or cord acquisition • Transplant
Appears in 1 contract